Literature DB >> 15580776

RNA interference: past, present and future.

Tessa N Campbell1, Francis Y M Choy.   

Abstract

RNA interference (RNAi) is the sequence-specific gene silencing induced by double-stranded RNA. RNAi is mediated by 21-23 nucleotide small interfering RNAs (siRNAs) which are produced from long double-stranded RNAs by RNAse II-like enzyme Dicer. The resulting siRNAs are incorporated into a RNA-induced silencing complex (RISC) that targets and cleaves mRNA complementary to the siRNAs. Since its inception in 1998, RNAi has been demonstrated in organisms ranging from trypanosomes to nematodes to vertebrates. Potential uses already in progress include the examination of specific gene function in living systems, the development of anti-viral and anti-cancer therapies, and genome-wide screens. In this review, we discuss the landmark discoveries that established the contextual framework leading up to our current understanding of RNAi. We also provide an overview of current developments and future applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580776

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  16 in total

1.  Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Authors:  Caren V Lund; Mikhail Popkov; Laurent Magnenat; Carlos F Barbas
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  esiRNAs purified with chromatography suppress homologous gene expression with high efficiency and specificity.

Authors:  Baoqin Xuan; Zhikang Qian; Chang Tan; Taishan Min; Shuiyuan Shen; Weida Huang
Journal:  Mol Biotechnol       Date:  2005-11       Impact factor: 2.695

Review 3.  Have we achieved a unified model of photoreceptor cell fate specification in vertebrates?

Authors:  Ruben Adler; Pamela A Raymond
Journal:  Brain Res       Date:  2007-03-20       Impact factor: 3.252

4.  Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNA-mediated gene silencing.

Authors:  Andrei B Borisov; Sarah B Sutter; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch; Margaret V Westfall; Mark W Russell
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

5.  Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.

Authors:  Bai Zhao; Tiemin Sun; Fanjuan Meng; Aibing Qu; Chunling Li; Hui Shen; Yu Jin; Wenxin Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-05       Impact factor: 4.553

6.  Epigenetic reprogramming of cancer cells via targeted DNA methylation.

Authors:  Ashley G Rivenbark; Sabine Stolzenburg; Adriana S Beltran; Xinni Yuan; Marianne G Rots; Brian D Strahl; Pilar Blancafort
Journal:  Epigenetics       Date:  2012-04-01       Impact factor: 4.528

7.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

Review 8.  Cancer gene therapy targeting angiogenesis: an updated review.

Authors:  Ching-Chiu Liu; Zan Shen; Hsiang-Fu Kung; Marie C M Lin
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

9.  In vivo and in vitro knockdown of FREP2 gene expression in the snail Biomphalaria glabrata using RNA interference.

Authors:  Yiguo Jiang; Eric S Loker; Si-Ming Zhang
Journal:  Dev Comp Immunol       Date:  2006-01-10       Impact factor: 3.636

Review 10.  X-chromosome inactivation: the molecular basis of silencing.

Authors:  Barbara Panning
Journal:  J Biol       Date:  2008-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.